1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Biotage AB (publ)

Biotage AB (publ)

BIOT.ST
Biotage AB (publ)SE flagStockholm Stock Exchange
143.20
SEK
+0.20
- -
11.46BMarket Cap

Total Valuation

Biotage AB (publ) carries a market capitalization of 11.46B, placing it among publicly traded companies globally. Its enterprise value stands at 7.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap11.46B
Enterprise Value7.47B

Share Statistics

Biotage AB (publ) currently has 80.05M shares outstanding.

Shares Outstanding80.05M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Biotage AB (publ) trades at a trailing price-to-earnings ratio of 29.91. The price-to-sales ratio is 3.90, and the price-to-book ratio stands at 4.63.

PE Ratio29.91
PS Ratio3.90
PB Ratio4.63
P/TBV Ratio10.53
P/FCF Ratio15.09
P/OCF Ratio22.00

Enterprise Valuation

On an enterprise value basis, Biotage AB (publ) trades at an EV/EBITDA multiple of 24.50 and an EV/FCF ratio of 14.71. The EV/Sales ratio of 3.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.50 provides insight into valuation relative to core operating earnings.

EV / Sales3.81
EV / EBITDA24.50
EV / EBIT24.50
EV / FCF14.71

Financial Position

Biotage AB (publ) maintains a current ratio of 2.53, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

Current Ratio2.53
Quick Ratio0.88
Debt / Equity6.19
Debt / EBITDA0.78
Interest CoverageN/A

Financial Efficiency

Biotage AB (publ) posts a return on equity of 16.12 and a return on invested capital of 6.41.

Return on Equity (ROE)16.12
Return on Assets (ROA)5.20
Return on Invested Capital (ROIC)6.41
Return on Capital Employed (ROCE)13.42
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.66

Taxes

Over the trailing twelve months, Biotage AB (publ) has paid 35.00M in income taxes, reflecting an effective tax rate of 12.03.

Income Tax35.00M
Effective Tax Rate12.03

Stock Price Statistics

Biotage AB (publ)'s stock has declined approximately -27.60364% over the past 52 weeks. The 50-day moving average sits at 142.47, while the 200-day moving average is 138.61.

Beta (5Y)N/A
52-Week Price Change-27.60364%
50-Day Moving Average142.47
200-Day Moving Average138.61
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Biotage AB (publ) generated 1.96B in revenue and converted that into 256.00M in net income, yielding earnings per share of 3.19. EBITDA reached 305.00M, while operating income came in at 305.00M.

Revenue1.96B
Gross Profit1.23B
Operating Income305.00M
Pretax Income291.00M
Net Income256.00M
EBITDA305.00M
EBIT305.00M
Earnings Per Share (EPS)3.19

Balance Sheet

Biotage AB (publ) holds 420.00M in cash and equivalents against 238.00M in total debt, resulting in a net debt position of -270.00M. Total book value stands at 1.65B, with working capital of 729.00M providing operational flexibility.

Cash & Cash Equivalents420.00M
Total Debt238.00M
Net Debt-270.00M
Equity (Book Value)1.65B
Book Value Per Share20.66
Working Capital729.00M

Cash Flow

Biotage AB (publ) produced 348.00M in operating cash flow over the past twelve months. After subtracting -160.00M in capital expenditures, free cash flow totaled 188.00M - equivalent to 2.35 per share.

Operating Cash Flow348.00M
Capital Expenditures-160.00M
Free Cash Flow188.00M
FCF Per Share2.35

Margins

Biotage AB (publ) operates with a gross margin of 62.67, reflecting its pricing power and cost economics. The operating margin of 15.55 and net profit margin of 13.05 provide insight into operational efficiency.

Gross Margin62.67
Operating Margin15.55
Pretax Margin14.84
Profit Margin13.05
EBITDA Margin15.55

Dividends & Yields

The company's payout ratio of 50.00 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share1.60
Dividend YieldN/A
Payout Ratio50.00
Shareholder Yield2.06
FCF Yield6.63

Scores

Biotage AB (publ) posts an Altman Z-Score of 9.10, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score9.10